WO2014073450A1 - 酒酔い軽減剤 - Google Patents
酒酔い軽減剤 Download PDFInfo
- Publication number
- WO2014073450A1 WO2014073450A1 PCT/JP2013/079581 JP2013079581W WO2014073450A1 WO 2014073450 A1 WO2014073450 A1 WO 2014073450A1 JP 2013079581 W JP2013079581 W JP 2013079581W WO 2014073450 A1 WO2014073450 A1 WO 2014073450A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tomato
- alcohol
- drunkenness
- soluble component
- insoluble
- Prior art date
Links
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 91
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 91
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 9
- 239000003638 chemical reducing agent Substances 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 5
- 235000015113 tomato pastes and purées Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 description 22
- 239000007788 liquid Substances 0.000 description 13
- 230000035622 drinking Effects 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000002269 spontaneous effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000700159 Rattus Species 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 235000013325 dietary fiber Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- -1 etc. Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000001814 pectin Substances 0.000 description 5
- 235000010987 pectin Nutrition 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000012223 aqueous fraction Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000006742 locomotor activity Effects 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XSAYZAUNJMRRIR-UHFFFAOYSA-N 2-acetylnaphthalene Chemical compound C1=CC=CC2=CC(C(=O)C)=CC=C21 XSAYZAUNJMRRIR-UHFFFAOYSA-N 0.000 description 1
- RYKKQQUKJJGFMN-HVDRVSQOSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol;(2s)-5-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC(=O)N1.CC1=NC=C(CO)C(CO)=C1O RYKKQQUKJJGFMN-HVDRVSQOSA-N 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- PSMFFFUWSMZAPB-UHFFFAOYSA-N Eukalyptol Natural products C1CC2CCC1(C)COCC2(C)C PSMFFFUWSMZAPB-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- XKYICAQFSCFURC-UHFFFAOYSA-N isoamyl formate Chemical compound CC(C)CCOC=O XKYICAQFSCFURC-UHFFFAOYSA-N 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000008379 phenol ethers Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Definitions
- the present invention relates to a drunkenness alleviating agent, and more particularly to a drunky alleviating agent that reduces drought or drunkness due to a large amount of drinking.
- Alcohol taken into the body by drinking is metabolized by mitochondria in hepatocytes and decomposed into acetaldehyde with strong hepatotoxicity, and then acetaldehyde is rapidly decomposed into acetic acid.
- Acetic acid is released from the liver into the blood, enters the TCA circuit as a source of energy for peripheral tissues, and is eventually broken down into carbon dioxide and water.
- a drunk reducing agent An edible composition for reducing the absorption of alcohol by a human or animal body is called a drunk reducing agent.
- Many drunkenness alleviating agents are effective based on blood alcohol and acetaldehyde concentration data. There are few examples of using drunk reducing agents to examine the reduction of drought or drunkness due to the effect of actually ingesting a large amount of alcohol.
- Patent Document 1 can help restore the functional structure of the liver, accelerate the elimination of alcohol from the blood and tissues, and prevent neuropsychological disorders associated with chronic alcoholism and related syndromes.
- a mitigating metadoxine composition is disclosed.
- Non-patent document 1 states that ethanol was administered to mice at 2 g / kg and the increase in blood acetaldehyde concentration was suppressed, but the blood ethanol concentration was about 1.6 mg / ml, which was mild to moderate. However, the behavior of animals is not examined, and there is no mention of the effect of reducing the effects of alcohol.
- Non-patent Document 2 the improvement effect on sickness caused by alcohol administration was investigated for the type vulnerable to alcohol, and stomach discomfort and nausea were reduced, but the alcohol dose was about 0.5 g / kg,
- the blood ethanol concentration is also between 0.4 and 0.8 mg / ml, and the evaluation is based on the amount of alcohol consumed that exhibits mild wrinkles, and the improvement effect over strength wrinkles has not been studied.
- Non-Patent Document 3 when tomato juice and alcohol are ingested at the same time, there is a possibility that the intoxication will be moderated and the intoxication after drinking may be accelerated, and as a cause thereof, There is a tendency to increase the activity of enzymes that metabolize alcohol and acetaldehyde in vivo, and in particular, it is described that the activity of LDH in the liver is significantly increased.
- the present invention solves the above-mentioned conventional problems, and an object of the present invention is to provide a drunk reducing agent capable of reducing the degree of drought or drunkness when drinking a large amount of alcohol.
- the present invention provides the use of an insoluble component of tomato in the preparation of a drunk reducing agent.
- the insoluble component of the tomato is a residue obtained by removing a water-soluble component from the tomato raw material.
- the insoluble component of the tomato is a residue obtained by removing a water-soluble component and a fat-soluble component from the tomato raw material.
- the tomato material is at least one selected from the group consisting of tomato fruit, dried tomato powder and squeezed rice cake after squeezing the tomato fruit.
- the removal of the fat-soluble component from the tomato raw material is performed by extraction using at least one selected from the group consisting of ethanol and ethyl acetate.
- the present invention also provides a drunk reducing agent containing an insoluble component of tomato.
- the drunkenness reducing agent of the present invention can reduce drought or drunkness when drinking a large amount of alcohol. Moreover, the drunkenness reducing agent of the present invention can be easily and safely ingested as an edible composition on a daily basis.
- the tomato referred to in the present invention is a variety of tomatoes conventionally used for food.
- Tomatoes include, for example, so-called pink tomatoes and red tomatoes.
- Tomato is a fruit that can be eaten raw.
- the tomato fruit in a ready-to-eat state is preferably a ripe fruit.
- tomato varieties include “Momotaro” (trade name), First Tomato, Mini Tomato, Plum Tomato, “Kinko Hime” (trade name), Cindy Sweet, Cindy Orange, Reward, Sunroad, Shurei, Palto, Raw tomatoes such as My Rock, Rinka 409, Renaissance, Reika, Reiko and Rokusanmaru, San Marzano, Chico No. 3, Kurikoma, Furikoma, High Peel, Kagome 77, KGM952, and KGM993 etc.
- Processing tomatoes, Aichi Examples include raw food processing tomatoes such as tomatoes, June pink and Ponterosa.
- Insoluble means insoluble in liquid.
- the liquid includes water and an organic solvent.
- An organic solvent here means the organic solvent which can melt
- Specific examples of organic solvents include alcohol solvents, ethanol, propanol, isopropanol, butanol, isobutanol, etc., ester solvents, ethyl acetate, ethyl acetoacetate, isoamyl formate, methyl cinnamate, etc., ketone solvents
- ether solvents such as acetophenone, ionone, methyl- ⁇ -naphthyl ketone, and ketones include 1,8-cineol, ethyl panillin, vanillin, ethers, phenol ethers, and the like.
- Preferred organic solvents are ethanol and ethyl acetate.
- Insoluble ingredients include water-insoluble dietary fiber.
- Dietary fiber refers to indigestible components that are not digested by digestive enzymes in the human body among the components of food.
- the insoluble component of tomato is a residue obtained by removing the water-soluble component from the tomato raw material. It is preferable that the insoluble component of tomato is obtained by removing the fat-soluble component.
- tomato materials include tomato fruit, dried tomato powder, and tomato squeezed strawberries. The tomato fruit may be after heating.
- tomato raw material is preferably tomato pomace.
- Tomato squeezed rice cake is a by-product in the production process of juice and the like, and is a residue obtained by squeezing tomato and then filtering and removing liquid components such as fruit juice.
- Tomato raw materials are washed, crushed and squeezed as necessary to remove as much liquid components as possible. However, it is not necessary to completely remove the liquid component. Thereafter, the tomato material from which the liquid component has been removed is subjected to a step of removing the water-soluble component and, if necessary, a step of removing the fat-soluble component. Either the step of removing the water-soluble component or the step of removing the fat-soluble component may be performed first. However, from the viewpoint of work efficiency, it is preferable to perform the step of removing the water-soluble component first.
- the step of removing the water-soluble component from the tomato raw material is, for example, putting the tomato raw material from which liquid components such as tomato pomace or dried tomato are removed as much as possible into water and stirring, and then the liquid part containing the water-soluble component By separating from the solid part. Separation of the liquid part and the solid part is performed by a commonly used method such as filtration and centrifugation.
- the step of removing the fat-soluble component from the tomato raw material is, for example, putting the tomato raw material from which liquid components such as tomato squeezed rice cake or dried tomato are removed as much as possible into the above organic solvent and stirring, and the liquid part containing the fat-soluble component By separating from the solid part. Separation of the liquid part and the solid part is performed by a commonly used method such as filtration and centrifugation.
- the insoluble component of the tomato obtained can be used as an anti-drunk agent.
- Tomato is a food and the insoluble components of tomato are harmless. Therefore, when the insoluble component of tomato is to be ingested by humans as an anti-drunk agent, the intake amount may be determined appropriately according to the purpose.
- the insoluble component of tomato is ingested in an amount of about 0.1 g / kg or more based on body weight. If the intake of insoluble components in tomato is less than 0.1 g / kg based on body weight, the effect of reducing drought or drunkness when drinking a large amount of alcohol is low. Note that 0.1 g / kg, which is a lower limit example of the intake, is 6 g when converted to the intake of a human body weight of 60 kg.
- the anti-drunk agent of the present invention may be taken before, during or after drinking.
- the anti-drunk agent of the present invention is excellent in effect and is characterized by exhibiting the effect of reducing drought or drunkenness even when ingested after drinking.
- an additive such as saccharides and excipients, or a liquid component may be used in combination with the insoluble component of tomato as long as the effects of the present invention are not impaired.
- the anti-drunk agent of the present invention may be prepared in the form of food or beverage.
- a form called a supplement is preferable, and a form such as a tablet or granule is preferable.
- As a beverage it is common to adjust to a form such as a drink. You may mix with alcoholic beverages.
- These foods or beverages may be produced by a conventional method. For example, it can be produced by the following method.
- additives such as excipients and sweeteners.
- additives such as excipients, sweeteners, lubricants are added and mixed, and then compressed into tablets using a rotary tableting machine, single-punch tableting machine, etc. Can be manufactured.
- excipients include starch (corn starch, potato starch, wheat starch, rice starch, etc.), lactose colloidal silica, crystalline cellulose, anhydrous silicic acid, anhydrous calcium phosphate, precipitated calcium carbonate, calcium silicate, light anhydrous silicic acid. Hydrous silicon dioxide, silicon dioxide, aluminum oxide, magnesium carbonate, precipitated calcium carbonate, crystalline cellulose, synthetic aluminum silicate, magnesium silicate, magnesium metasilicate aluminate, dextrin, carmellose calcium and the like. These carriers may be used alone or in combination of two or more.
- the crystalline cellulose includes microcrystalline cellulose.
- sweetener examples include sugar, sugar alcohol, glucose, fructose, galactose, mannose, lactose, maltose, sucrose, sucrose (including purified sucrose), trehalose, mannitol, sorbitol, maltitol, aspartame, erythritol. Xylitol and the like, and these may be used alone or in combination of two or more.
- the lubricant examples include magnesium stearate, calcium stearate, sodium stearyl fumarate, stearic acid, talc, sucrose fatty acid ester, glycerin fatty acid ester, polyethylene glycol, vegetable oil and the like.
- the lubricant may be added by any of the method of adding to the granule before tableting and mixing, or the method of adhering directly to the punch or die during tableting.
- Rats were forcibly intragastricly administered with 4 g / kg of ethanol, a dose that reached the blood ethanol concentration (Tsukamoto et al., Medicina, 2005), which is from the high-strength period in humans to the drunk period. Thirty minutes later, the test substance was dissolved or suspended in water and administered into the forced stomach, and the subsequent locomotor activity was examined over time. As a test object, the material shown below was employ
- Example 1 Tomato dry powder (variety: Renaissance, manufactured by Ishikawa Farm Co., Ltd.) 2.367g of whole raw tomato powder is added to 40ml of distilled water, vortexed vigorously for 2 minutes, centrifuged (3000rpm, 10 minutes), The clear aqueous fraction and residue were separated. 10 ml of distilled water was added to the obtained tomato residue to make a suspension. A suspension of 16.9 ml / kg was administered by gavage. The weight of the residue obtained by this treatment is 15.7%, which is equal to the dietary fiber content in the tomato dry powder, and its dosage is 0.63 g / kg corresponding to 4 g / kg of tomato dry powder. It was.
- Example 1 The aqueous fraction separated from the tomato residue by the operation of Example 1 was concentrated by distillation under reduced pressure until the volume reached 10 ml. A concentrated solution of 16.9 ml / kg was administered by gavage.
- Example 2 The same operation as in Example 1 was performed to obtain a tomato residue.
- the obtained tomato residue was put in 500 ml of ethanol and stirred for 1 hour, and then the filtered residue was next put in 500 ml of ethyl acetate, stirred for 5 hours and then filtered again to dry the residue overnight.
- tomato residue obtained by extraction was obtained.
- 10 ml of distilled water was added to the obtained tomato residue to make a suspension.
- a suspension of 16.9 ml / kg was administered by gavage. The dosage was 0.63 g / kg corresponding to 4 g / kg of tomato dry powder.
- FIG. 1 shows the results of Example 1, Comparative Example 1 and Example 2. From this result, it was confirmed that the tomato residue has an effect of reducing the degree of drought or drunkness, the effect is enhanced by the extracted tomato residue, and is hardly observed in the aqueous fraction of tomato. .
- Pectin and cellulose were forcibly administered intragastrically at 16.9 ml / kg to a solution suspended in distilled water to 3.74% to 0.63 g / kg.
- Example 3 In order to examine the effective amount of tomato residue, the extraction-treated tomato residue was produced in the same manner as in Example 2, and the dosage was 0.3 g / kg, 0.1 g / kg, 0.05 g / kg, and 0. Spontaneous momentum of the rat at 025 g / kg was examined.
- Example 3 The results of Example 3 are shown in FIG. It was confirmed that the effect of reducing the degree of drunkenness or drunkness by the tomato residue subjected to the extraction treatment is exhibited at a dose of 0.1 g / kg or more.
- the ethanol concentration in blood by administration of 4 g / kg of alcohol is around 3 mg / ml, which is the result of drinking about 5 large beer bottles in terms of humans.
- a human with a body weight of 60 kg it is considered that if 6 g or more of the extracted tomato residue is ingested, the effect of reducing drought or drunkness can be obtained.
- the drunk prevention agent of the present invention can be used as food or beverage.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012-247246 | 2012-11-09 | ||
JP2012247246A JP6012415B2 (ja) | 2012-11-09 | 2012-11-09 | 酒酔い軽減剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014073450A1 true WO2014073450A1 (ja) | 2014-05-15 |
Family
ID=50684558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/079581 WO2014073450A1 (ja) | 2012-11-09 | 2013-10-31 | 酒酔い軽減剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6012415B2 (enrdf_load_stackoverflow) |
WO (1) | WO2014073450A1 (enrdf_load_stackoverflow) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6573756B2 (ja) * | 2014-08-22 | 2019-09-11 | アサヒグループホールディングス株式会社 | トマト含有飲食品 |
JP2016086715A (ja) * | 2014-10-31 | 2016-05-23 | アサヒグループホールディングス株式会社 | ニンジン由来成分含有飲食品 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007246478A (ja) * | 2006-03-17 | 2007-09-27 | Kagome Co Ltd | アセトアルデヒド代謝促進剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5424940A (en) * | 1977-07-26 | 1979-02-24 | Kagome Kk | Production of carotinoid containing substance for coloring food |
IL146496A0 (en) * | 2001-11-14 | 2002-07-25 | Lycored Natural Prod Ind Ltd | Carotenoid composition and method for protecting skin |
ES2322757T3 (es) * | 2003-08-21 | 2009-06-26 | Nestec S.A. | Concentrado natural de licopeno y procedimiento de obtencion. |
KR101092197B1 (ko) * | 2009-11-11 | 2011-12-13 | 남종현 | 토마토 전초 추출물을 유효성분으로 하는 지방간 개선용 식품조성물 |
-
2012
- 2012-11-09 JP JP2012247246A patent/JP6012415B2/ja active Active
-
2013
- 2013-10-31 WO PCT/JP2013/079581 patent/WO2014073450A1/ja active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007246478A (ja) * | 2006-03-17 | 2007-09-27 | Kagome Co Ltd | アセトアルデヒド代謝促進剤 |
Non-Patent Citations (3)
Title |
---|
ASAHI GROUP: "Kagome Kyodo Kenkyu Tomato ga Inshugo no Kecchu Alcohol Nodo o Teika saseru Koto o Hito de Kakunin -Yoi no Mawari ga Yuruyaka ni nari, Inshugo no Yoizame mo Hayamaru Kanosei ga Shisa", NEWS RELEASE, KAGOME CO., LTD., 25 May 2012 (2012-05-25), KAGOME CO., LTD, Retrieved from the Internet <URL:http://www.kagome.co.jp/Co./news/2012/05/001371.html> [retrieved on 20131206] * |
EVANS, RANDOLPH W. ET AL.: "Alcohol hangover headache.", HEADACHE, vol. 47, 2007, pages 277 - 279 * |
KURCER MEHMET ALI ET AL.: "Effect of lycopene on caspase-3 enzyme activation in liver of methanol-intoxicated rats: comparison with fomepizole", JOURNAL OF MEDICINAL FOOD, vol. 13, no. 4, 2010, pages 985 - 991 * |
Also Published As
Publication number | Publication date |
---|---|
JP6012415B2 (ja) | 2016-10-25 |
JP2014094916A (ja) | 2014-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010209051A (ja) | 脂肪吸収抑制剤 | |
JP2013501772A (ja) | 全バナナ(MusaSpp.)果実からの天然抽出物 | |
EP2683256B1 (fr) | Composition nutraceutique pour limiter l'absorption de lipides alimentaires et pour induire une perte de poids comprenant comme agent actif au moins un extrait de carotte | |
JP6012415B2 (ja) | 酒酔い軽減剤 | |
JP2005185188A (ja) | アセロラ処理物およびl−カルニチン含有組成物 | |
KR101045279B1 (ko) | 비만억제효능을 갖는 기능성 식품의 조성물 | |
JP6220792B2 (ja) | 血中アセトアルデヒド低減剤 | |
JP2009050196A (ja) | 食品組成物 | |
CN102100810A (zh) | 一种具有抗氧化功能的中药组合物及其制备方法 | |
JP2004035510A (ja) | 糖尿病又はその合併症の予防または治療用組成物 | |
JP6573756B2 (ja) | トマト含有飲食品 | |
JP2001269135A (ja) | 体タンパク質蓄積効率を亢進する栄養組成物 | |
CN110856715B (zh) | 含有藤茶萃取物的组合物、片剂及胶囊剂 | |
JP5801515B1 (ja) | トマト含有飲食品 | |
JP2005082546A (ja) | α−グルコシダーゼ阻害剤 | |
JP6689752B2 (ja) | 果物由来成分含有飲食品 | |
US20240207327A1 (en) | Composition including propolis and sorbus commixta as active ingredients for alleviating and treating inflammatory diseases and allergic diseases | |
JP2011111421A (ja) | むくみの予防又は改善作用を有する組成物 | |
JP2005237290A (ja) | 健康食品 | |
JP2009023948A (ja) | ドーパミン抑制剤 | |
TW202448838A (zh) | 製備薑油酮之方法、包含薑油酮之組成物、及其用途 | |
JP2005278654A (ja) | 関節炎改善用食品 | |
JP2009280501A (ja) | 内臓脂肪蓄積抑制剤 | |
JP5066394B2 (ja) | ゲンクワニン5−O−β−プリメベロシドの抽出方法 | |
JP6940864B2 (ja) | 精巣障害予防及び/又は改善剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13853554 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13853554 Country of ref document: EP Kind code of ref document: A1 |